Ginkgo Bioworks Holdings, Inc. (DNA) |
|
3.12 -0.01 (-0.32%)
|
10-02 21:43 |
|
Open: |
3.12 |
Pre. Close: |
3.13 |
|
High:
|
3.41 |
Low:
|
3.09 |
|
Volume:
|
28,130,986 |
Market Cap:
|
5,851(M) |
|
|
|
|
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.41 - 3.43 |
3.43 - 3.45 |
|
Low:
|
3.05 - 3.07 |
3.07 - 3.09 |
|
Close:
|
3.09 - 3.12 |
3.12 - 3.15 |
|
Technical analysis |
as of: 2022-09-30 4:27:30 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 4.07 One year: 4.76 |
| Support: |
Support1: 2.78 Support2: 2.34 |
| Resistance: |
Resistance1: 3.49 Resistance2: 4.07 |
| Pivot: |
3.02  |
| Moving Average: |
MA(5): 3.08 MA(20): 2.93
MA(100): 2.92 MA(250): 5.58  |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 70.3 %D(3): 67.1 |
| RSI: |
RSI(14): 53.6 |
| 52-week: |
High: 15.86 Low: 2.08 |
| Average Vol(K): |
3-Month: 25,090 (K) 10-Days: 25,348 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ DNA ] has closed below upper band by 35.8%. Bollinger Bands are 40.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Sun, 02 Oct 2022
Studying yeast DNA in space may help protect astronauts from cosmic radiation - The Conversation
Sun, 02 Oct 2022
A transition phase in late mouse oogenesis impacts DNA methylation of the early embryo | Communications Biology - Nature.com
Sat, 01 Oct 2022
Newsom Signs Bill to Protect Sexual Assault Victims' DNA - NBC Bay Area
Sat, 01 Oct 2022
How police can use your DNA to solve crimes without consent - New York Post
Fri, 30 Sep 2022
COVID Attacks DNA in Heart, Unlike Flu, Study Says - WebMD
Fri, 30 Sep 2022
Illumina pitches $200 genomes with new line of DNA sequencers - FierceBiotech
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
1,190 (M) |
| Shares Float |
790 (M) |
|
% Held by Insiders
|
6 (%) |
|
% Held by Institutions
|
77.6 (%) |
|
Shares Short
|
179,060 (K) |
|
Shares Short P.Month
|
150,270 (K) |
Stock Financials |
|
EPS
|
-1.68 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.93 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-562.5 |
|
Return on Assets (ttm)
|
-146.9 |
|
Return on Equity (ttm)
|
-309 |
|
Qtrly Rev. Growth
|
231.3 |
|
Gross Profit (p.s.)
|
0.15 |
|
Sales Per Share
|
0.45 |
|
EBITDA (p.s.)
|
-2.53 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-290 (M) |
|
Levered Free Cash Flow
|
904 (M) |
Stock Valuations |
|
PE Ratio
|
-1.87 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
3.31 |
|
Price to Sales
|
6.88 |
|
Price to Cash Flow
|
-12.81 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
